A Study of (Interleukin-12) IL-12 in Patients With Acute Myelogenous Leukemia (AML)
A Study of (Interleukin-12) IL-12 in Patients With Acute Myelogenous Leukemia (AML)
Active, not recruiting · NCT02483312 · Registry updated 2025-12-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of (Interleukin-12) IL-12 in Patients With Acute Myelogenous Leukemia (AML) | Disease Attributes, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Active, not recruiting | Phase 1 | 2025-12-01 | NCT02483312 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Ozmosis Research Inc. | 7 |
| University Health Network, Toronto | 417 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Princess Margaret Centre Centre | Toronto | Canada | 1 |